The Robert J Kleberg, Jr and Helen C Kleberg Foundation Medical Research Grant funds highly innovative and groundbreaking medical research proposals from top tier institutions in both basic biological and applied research that will have the greatest impact on scientific knowledge and human health. Proposals should be distinctive and novel in their approaches, bot being done elsewhere, question the prevailing paradigm, and lead to advancement in knowledge in the field. In general, the Kleberg Foundation has a strong preference for projects based in or studying topics of particular relevance to South Texas. Areas of particular interest to the Kleberg Foundation include cancer, especially glioblastoma and lung cancer; neurodegenerative disease, especially Alzheimer's; and vaccine development toward diseases that are prevalent in South Texas. Applications that address COVID-related research, aging-related research, ovarian cancer, and rare diseases are not responsive to this funding opportunity.
The Kleberg Foundation holds 2 cycles per year (Fall/Spring).
Budget: No limit; awards are typically $1 - 1.3 million over 3 years
Nominations Allowed: 1
Key Dates
| Fall Cycle | Spring Cycle | |
| May 12 | November 18 | Internal RFA release |
| June 9 | December 16 | Internal PreApplication Deadline |
| September 28 | March 31 | Sponsor Deadline |
Fall 2026 UTMB Internal RFA